Marco Goeijenbier

2.3k total citations
59 papers, 1.4k citations indexed

About

Marco Goeijenbier is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Marco Goeijenbier has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 17 papers in Public Health, Environmental and Occupational Health and 16 papers in Epidemiology. Recurrent topics in Marco Goeijenbier's work include Viral Infections and Vectors (23 papers), Viral Infections and Outbreaks Research (14 papers) and Mosquito-borne diseases and control (11 papers). Marco Goeijenbier is often cited by papers focused on Viral Infections and Vectors (23 papers), Viral Infections and Outbreaks Research (14 papers) and Mosquito-borne diseases and control (11 papers). Marco Goeijenbier collaborates with scholars based in Netherlands, United States and Indonesia. Marco Goeijenbier's co-authors include Eric C. M. Van Gorp, Chantal Reusken, Marion Koopmans, Albert D. M. E. Osterhaus, Joost C.M. Meijers, Matthijs Van Wissen, D.P.M. Brandjes, Victor E. A. Gerdes, Eefje Jong and Ron A. M. Fouchier and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Marco Goeijenbier

59 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Goeijenbier Netherlands 22 742 412 227 178 127 59 1.4k
Arnaud G. L’Huillier Switzerland 21 930 1.3× 553 1.3× 140 0.6× 117 0.7× 115 0.9× 89 1.5k
Maria K. Smatti Qatar 17 604 0.8× 366 0.9× 84 0.4× 212 1.2× 217 1.7× 34 1.3k
Marie Helleberg Denmark 26 1.2k 1.6× 758 1.8× 141 0.6× 187 1.1× 137 1.1× 113 2.3k
Ji‐Man Kang South Korea 20 528 0.7× 289 0.7× 75 0.3× 105 0.6× 109 0.9× 94 1.5k
Daniel S. Chertow United States 20 955 1.3× 719 1.7× 170 0.7× 246 1.4× 337 2.7× 58 1.9k
Elizabeth J. McFarland United States 23 952 1.3× 724 1.8× 102 0.4× 690 3.9× 231 1.8× 62 2.2k
José F. Camargo United States 24 780 1.1× 790 1.9× 99 0.4× 355 2.0× 145 1.1× 88 1.8k
Clare A. Dykewicz United States 15 450 0.6× 821 2.0× 114 0.5× 118 0.7× 153 1.2× 22 1.6k
Athanasios Michos Greece 22 643 0.9× 524 1.3× 233 1.0× 89 0.5× 195 1.5× 98 1.4k
Julien Beauté Sweden 22 545 0.7× 617 1.5× 309 1.4× 461 2.6× 82 0.6× 36 1.6k

Countries citing papers authored by Marco Goeijenbier

Since Specialization
Citations

This map shows the geographic impact of Marco Goeijenbier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Goeijenbier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Goeijenbier more than expected).

Fields of papers citing papers by Marco Goeijenbier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Goeijenbier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Goeijenbier. The network helps show where Marco Goeijenbier may publish in the future.

Co-authorship network of co-authors of Marco Goeijenbier

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Goeijenbier. A scholar is included among the top collaborators of Marco Goeijenbier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Goeijenbier. Marco Goeijenbier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leeuwen, Leanne P. M. van, Jacques du Toit, Kevin K. Brown, et al.. (2025). Bloodstream Infections and Colonization in Hematopoietic Stem Cell Transplant Recipients at a South African Center: A Retrospective Analysis. Transplantation and Cellular Therapy. 31(4). 269.e1–269.e13. 1 indexed citations
2.
Sande, Davy van de, et al.. (2025). Comparative evaluation and performance of large language models on expert level critical care questions: a benchmark study. Critical Care. 29(1). 72–72. 8 indexed citations
3.
4.
Goeijenbier, Marco, Dennis Souverein, Michael Nagel, et al.. (2024). Post COVID-19 Pandemic Increased Detection of Mycoplasma Pneumoniae in Adults Admitted to the Intensive Care. Journal of Clinical Medicine. 13(12). 3443–3443. 2 indexed citations
5.
Goeijenbier, Marco, et al.. (2023). Early Patient-Triggered Pressure Support Breathing in Mechanically Ventilated Patients with COVID-19 May Be Associated with Lower Rates of Acute Kidney Injury. Journal of Clinical Medicine. 12(5). 1859–1859. 1 indexed citations
6.
Rokx, Casper, Els van Nood, Eric C. M. Van Gorp, et al.. (2023). Levels of Fibrinogen Variants Are Altered in Severe COVID-19. SHILAP Revista de lepidopterología. 7(3). e217–e225. 5 indexed citations
7.
Kakoullis, Loukas, Robert Steffen, Albert D. M. E. Osterhaus, et al.. (2023). Influenza: seasonality and travel-related considerations. Journal of Travel Medicine. 30(5). 12 indexed citations
8.
Noack, Danny, Maja Travar, Jolanda J.C. Voermans, et al.. (2022). Serum Markers Associated with Disease Severity in a Bosnian Hemorrhagic Fever with Renal Syndrome Cohort. Viruses. 14(7). 1377–1377. 3 indexed citations
9.
Slotman, Johan A., Coen Maas, Hannelore I. Bax, et al.. (2022). Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID‐19, not entirely explaining the increased risk of thrombosis. Journal of Thrombosis and Haemostasis. 20(6). 1412–1420. 10 indexed citations
10.
Hadi, Usman, et al.. (2020). Point-of-care thrombocyte function testing using multiple-electrode aggregometry in dengue patients: an explorative study. BMC Infectious Diseases. 20(1). 580–580. 6 indexed citations
11.
Rönnberg, Bengt, Olli Vapalahti, Marco Goeijenbier, et al.. (2017). Serogrouping and seroepidemiology of North European hantaviruses using a novel broadly targeted synthetic nucleoprotein antigen array. Infection Ecology & Epidemiology. 7(1). 1350086–1350086. 3 indexed citations
12.
Short, Kirsty R., Jennifer Kasper, Arno C. Andeweg, et al.. (2016). Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions. European Respiratory Journal. 47(3). 954–966. 188 indexed citations
13.
Goeijenbier, Marco, Perry J.J. van Genderen, Brian J. Ward, et al.. (2016). Travellers and influenza: risks and prevention. Journal of Travel Medicine. 24(1). taw078–taw078. 34 indexed citations
14.
Goeijenbier, Marco, Georgina I. Aron, Åke Lundkvist, et al.. (2015). Emerging Viruses in the Republic of Suriname: Retrospective and Prospective Study into Chikungunya Circulation and Suspicion of Human Hantavirus Infections, 2008–2012 and 2014. Vector-Borne and Zoonotic Diseases. 15(10). 611–618. 8 indexed citations
15.
Goeijenbier, Marco, Eric C. M. Van Gorp, Barry Rockx, et al.. (2015). Seoul hantavirus in brown rats in the Netherlands: implications for physicians--Epidemiology, clinical aspects, treatment and diagnostics.. PubMed. 73(4). 155–60. 19 indexed citations
16.
Goeijenbier, Marco, Koert J. Stittelaar, Kamran Bakhtiari, et al.. (2014). Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets. BMC Microbiology. 14(1). 134–134. 23 indexed citations
17.
Kreijtz, Joost H. C. M., Marco Goeijenbier, Michael H. Lehmann, et al.. (2014). Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial. The Lancet Infectious Diseases. 14(12). 1196–1207. 72 indexed citations
18.
Goris, Marga G. A., Masja Straetemans, Sandra Alba, et al.. (2013). Towards the Burden of Human Leptospirosis: Duration of Acute Illness and Occurrence of Post-Leptospirosis Symptoms of Patients in The Netherlands. PLoS ONE. 8(10). e76549–e76549. 39 indexed citations
19.
Goeijenbier, Marco, Matthijs Van Wissen, Eefje Jong, et al.. (2012). Review: Viral infections and mechanisms of thrombosis and bleeding. Journal of Medical Virology. 84(10). 1680–1696. 203 indexed citations
20.
Goeijenbier, Marco, Erfan Nur, Marina Goris, et al.. (2011). An unusual cause of a usual presentation. The Netherlands Journal of Medicine. 69(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnaud G. L’Huillier Breakdown of academic impact, for papers by Maria K. Smatti Breakdown of academic impact, for papers by Marie Helleberg Breakdown of academic impact, for papers by Ji‐Man Kang Breakdown of academic impact, for papers by Daniel S. Chertow Breakdown of academic impact, for papers by Elizabeth J. McFarland Breakdown of academic impact, for papers by José F. Camargo Breakdown of academic impact, for papers by Clare A. Dykewicz Breakdown of academic impact, for papers by Athanasios Michos Breakdown of academic impact, for papers by Julien Beauté
Rankless by CCL
2026